2023-11-26 16:28:45
Andrzej Tokarski – stock.adobe.com
EXPERT OPINION – The synergy established between AI and drug sciences has opened the way to drugs better adapted to the specificities of patients.
Philippe Moingeon is a member of the Academy of Pharmacy. Associate professor of artificial intelligence and pharmaceutical sciences, Paris-Saclay University.
Artificial intelligence (AI) is profoundly transforming our approach to the design of new drugs, with today concrete achievements and dizzying prospects. Over the past five years, advances in AI have made it an essential tool in academic and industrial laboratories dedicated to drug research. This revolution is not confined to specialized circles, but affects each of us, significantly changing the way we approach illnesses.
The fruit of more than seventy years of research, AI today takes advantage of the computing power of contemporary computers and access to enormous quantities of data. It represents a convergence of technologies aimed at creating machines inspired by the human brain, capable of perceiving, analyzing…
This article is reserved for subscribers. You have 79% left to discover.
Black Friday
-70% on digital subscription
Already subscribed? Log in
#Drugs #designed #reality #serving #patients